Agoria, pharma.be & ISPE Belgium are delighted to invite their members to their joint event entitled “Unleashing Innovation” to learn about this digital revolution and boost and strengthen the exchange of innovative ideas, technologies and applications between the pharmaceutical and technology industries.
Two paradigm shifts drive the revolution. Firstly, the availability of big data and the emergence of new digital health technologies(eHealth, mobile apps, sensors, …) revolutionise the organisation of healthcare and make pharmaceutical solutions ever more patient-centric. Secondly, pharmaceutical companies are moving beyond the pill, recognising the need to develop more personalised treatment solutions. To further enable this evolution, pharmaceutical manufacturing operations need to evolve, by embracing Industry 4.0 – the integration of physical and information flows in cyber-physical production systems and by adopting new technologies and partnerships to make their production infrastructure more efficient.
15.30 WELCOME & REGISTRATION
16.00 UNLEASHING INNOVATION: PLENARY SESSION
Keynotes & speakers:
Associate principal, McKinsey
Author of the report
‘The Road to Digital Success in Pharma’
Jo De Boeck
Chief Technology Officer & Senior VP, imec
Professor, Department of Electrical Engineering, KU Leuven
President & CEO, ISPE
Director Business Communities, Agoria
17.00 PARALLEL TRACKS
PHARMACEUTICAL PRODUCTION: THE ROAD TO PHARMA FACTORY 4.0
Traditional manufacturing and quality functions will struggle to keep pace with the digital revolution and need for more personalized medicine. By embracing ‘Industry 4.0’ and by adopting new technologies and partnerships to make their production infrastructure more efficient pharmaceutical and life science companies will be able to better cope with the increasing market and regulatory demands and thus enable the future of pharmaceutical production.
Thomas Zimmer, PhD
Vice President European Operations, ISPE,
Senior consultant, Moelgaard Consulting
former VP Engineering & Business Operations, GlaxoSmithKline Vaccines
The availability of big data and the emergence of innovative IT-solutions (eHealth, mobile apps, sensors, …) fundamentally change the relationship between doctor and patient and the development and delivery of drugs, revolutionising the organisation of healthcare. This session offers a glimpse into how the digital era will further reshape the world of healthcare and the new role pharmaceutical companies will play.
Head of Unit, DG CONNECT, European Commission
Herman De Prins
Jeroen Aerssens, PhD
Senior Scientific Director, Janssen Pharmaceutica
Digital Lead Global Innovative Pharma, Pfizer